{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:59:42Z","timestamp":1792101582170,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Misr International University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>An ecofriendly, sensitive, selective, precise, and accurate HPLC method with fluorescence detection (FD) has been developed and validated for simultaneous determination of two hypertensive drugs, felodipine and metoprolol in their pure samples, combined pharmaceutical dosage form and in spiked human plasma. Separation was carried out on Inertsil C<jats:sub>18<\/jats:sub> column (150 mm\u2009\u00d7\u20094.6 ID; Particle size 5 \u00b5m) and a mobile phase composed of ethanol and 30mM potassium dihydrogen phosphate buffer, adjusted to pH 2.5 using ortho-phosphoric acid (40:60, v\/v) was used. A constant flow rate of 1.0 mL\/min at an ambient temperature was adopted. Method validation was performed according to the ICH Q2 R2 and bioanalytical method validation was done according to FDA guidelines for determination of both drugs simultaneously in biological matrices. The method demonstrated excellent linearity over the concentration range of 0.01\u20131.00 \u00b5g\/mL and 0.003\u20131.00 \u00b5g\/mL that were selected with accordance to the C<jats:sub>max<\/jats:sub> of both drugs with a correlation coefficient (r<jats:sup>2<\/jats:sup>) of 0.9998 and 0.9999 for felodipine and metoprolol, respectively in human plasma. The intra-day and inter-day precision were\u2009\u2264\u20092% in their pure forms and in spiked human plasma, and the accuracy was within\u2009\u00b1\u20092% of the nominal concentration for both drugs in their pure forms and within\u2009\u00b1\u200910% of the nominal concentration in human plasma. A statistical comparison was conducted between the proposed method and the reported method; it showed no significant difference between both methods regarding both accuracy and precision. The proposed method proved to be eco-friendly with three green assessment tools (AGREE calculator, MoGAPI, RGBfast study).<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1186\/s13065-025-01507-0","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T19:15:35Z","timestamp":1748027735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An eco-friendly bioanalytical RP-HPLC method coupled with fluorescence detection for simultaneous estimation of felodipine and metoprolol"],"prefix":"10.1186","volume":"19","author":[{"given":"Mariam Wasim","family":"Beniamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira Mohamed","family":"Kessiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha Abdelmonem","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Emad","family":"El Gendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna Ahmed","family":"Kormod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"1507_CR1","unstructured":"World Health Organization. Cardiovascular diseases (CVDs). 2021. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds). Accessed 4 April 2024."},{"key":"1507_CR2","doi-asserted-by":"publisher","unstructured":"John RV, Devasia T, Adigal SS, Lukose J, Kartha VB, Chidangil S. Serum protein profile study of myocardial infarction using a LED-induced fluorescence-based HPLC system. J Chromatogr B. 2023;1217:123616. https:\/\/doi.org\/10.1016\/j.jchromb.2023.123616. Accessed 4 April 2024.","DOI":"10.1016\/j.jchromb.2023.123616"},{"issue":"4","key":"1507_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0885066613503294","volume":"30","author":"N Makki","year":"2013","unstructured":"Makki N, Brennan TM, Girotra S. Acute coronary syndrome. J Intensive Care Med. 2013;30(4):186\u2013200.","journal-title":"J Intensive Care Med"},{"key":"1507_CR4","doi-asserted-by":"crossref","unstructured":"Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC\/AHA\/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation. 1999;99(21):2829\u201348.","DOI":"10.1161\/01.CIR.99.21.2829"},{"issue":"5\u20136","key":"1507_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/j.1552-4604.1974.tb02309.x","volume":"14","author":"JR Crout","year":"1974","unstructured":"Crout JR. Fixed combination prescription drugs: FDA policy. J Clin Pharmacol. 1974;14(5\u20136):249\u201354.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"1507_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.2165\/00003495-198223060-00003","volume":"23","author":"GM Shenfield","year":"1982","unstructured":"Shenfield GM. Fixed combination drug therapy. Drugs. 1982;23(6):462\u201380.","journal-title":"Drugs"},{"issue":"2","key":"1507_CR7","first-page":"348","volume":"3","author":"AH Kamal","year":"2016","unstructured":"Kamal AH, El-Malla SF, Hammad SF. A review on UV spectrophotometric methods for simultaneous multicomponent analysis. Eur J Pharm Med Res. 2016;3(2):348\u201360.","journal-title":"Eur J Pharm Med Res"},{"issue":"9","key":"1507_CR8","first-page":"3369","volume":"4","author":"L Hu","year":"2013","unstructured":"Hu L, Hu Q, Gao N. A validated, stability-indicating HPLC method for the determination of felodipine and its related substances. Int J Pharm Sci Res. 2013;4(9):3369.","journal-title":"Int J Pharm Sci Res"},{"key":"1507_CR9","doi-asserted-by":"crossref","unstructured":"Malli K, Kumar L, Verma R. Felodipine: review of analytical methods developed for pharmaceutical dosage forms and biological fluids. Int J Appl Pharm. 2023;53\u20139.","DOI":"10.22159\/ijap.2023v15i6.49211"},{"issue":"2","key":"1507_CR10","first-page":"449","volume":"13","author":"D Wang","year":"2014","unstructured":"Wang D, Li F, Jiang Z, Yu L, Guo X. Chiral recognition mechanisms of four beta-blockers by HPLC with amylose chiral stationary phase. Iran J Pharm Res. 2014;13(2):449\u201357.","journal-title":"Iran J Pharm Res"},{"issue":"Suppl 3","key":"1507_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2165\/00003495-198700343-00004","volume":"34","author":"B Ljung","year":"1987","unstructured":"Ljung B, Nordlander M. Pharmacodynamic properties of felodipine. Drugs. 1987;34(Suppl 3):7\u201315.","journal-title":"Drugs"},{"key":"1507_CR12","volume-title":"British Pharmacopoeia 2020","author":"British Pharmacopoeia Commission","year":"2020","unstructured":"British Pharmacopoeia Commission. British Pharmacopoeia 2020, vol. 1. London: The Stationery Office; 2020."},{"key":"1507_CR13","volume-title":"British Pharmacopoeia 2020","author":"British Pharmacopoeia Commission","year":"2020","unstructured":"British Pharmacopoeia Commission. British Pharmacopoeia 2020, vol. 2. London: The Stationery Office; 2020."},{"key":"1507_CR14","unstructured":"PubChem. Metoprolol tartrate. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Metoprolol-tartrate. Accessed 4 April 2024."},{"key":"1507_CR15","unstructured":"USP Monographs: Felodipine. USP29-NF24 P884, vol. 27. Pharmacopeia.cn."},{"key":"1507_CR16","unstructured":"USP Monographs: Metoprolol tartrate. USP29-NF24 P1420, vol. 29."},{"issue":"18","key":"1507_CR17","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1080\/10826070600923241","volume":"29","author":"MA Rontogianni","year":"2006","unstructured":"Rontogianni MA, Markopoulou CK, Koundourellis JE. HPLC and chemometrically-assisted spectrophotometric estimation of two binary mixtures for combined hypertension therapy. J Liq Chromatogr Relat Technol. 2006;29(18):2701\u201319.","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"9","key":"1507_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3844\/ajassp.2007.709.717","volume":"4","author":"H Salem","year":"2007","unstructured":"Salem H, Abdallah OM. Determination of metoprolol and felodipine in binary mixture using chemometric-assisted spectrophotometric and high-performance liquid chromatographic-UV methods. Am J Appl Sci. 2007;4(9):709\u201317.","journal-title":"Am J Appl Sci"},{"key":"1507_CR19","doi-asserted-by":"crossref","unstructured":"Walash MI, Belal F, El-Enany N, Mahmoud El M. Synchronous fluorescence spectrofluorimetric method for the simultaneous determination of metoprolol and felodipine in combined pharmaceutical preparation. Chem Cent J. 2011;5(1).","DOI":"10.1186\/1752-153X-5-70"},{"issue":"2","key":"1507_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/bmc.3536","volume":"30","author":"AMI Mohamed","year":"2015","unstructured":"Mohamed AMI, Omar MA, Hammad MA, Mohamed AA. Development and validation of TLC-densitometric method for simultaneous determination of two binary antihypertensive mixtures containing felodipine in fixed-dose combinations. Biomed Chromatography. 2015;30(2):200\u20137.","journal-title":"Biomed Chromatography"},{"issue":"4","key":"1507_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/jaoacint\/qsz040","volume":"103","author":"AA Emam","year":"2020","unstructured":"Emam AA, Naguib IA, Hassan ES, Abdelaleem EA. Development and validation of RP-HPLC and an eco-friendly HPTLC method for simultaneous determination of felodipine and metoprolol succinate, and their major metabolites in human spiked plasma. J AOAC Int. 2020;103(4):966\u201371.","journal-title":"J AOAC Int"},{"key":"1507_CR22","unstructured":"Li Z-Q, Wu F. Determination of felodipine and metoprolol tartrate in compound felodipine sustained-release tablets. 2004;39:693\u20134."},{"issue":"7","key":"1507_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2116\/analsci.33.755","volume":"33","author":"M Chen","year":"2017","unstructured":"Chen M, Zhou J, Mei L, Yu F, Xie X, Liu Y, et al. Simultaneous determination of felodipine and metoprolol in Beagle dog plasma by online SPE-LC-MS\/MS and its application in a pharmacokinetic study. Anal Sci. 2017;33(7):755\u20139.","journal-title":"Anal Sci"},{"issue":"4","key":"1507_CR24","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.26452\/ijrps.v11i4.4763","volume":"11","author":"R Potturi","year":"2020","unstructured":"Potturi R, Kantipudi R. Method development and validation of metoprolol and felodipine using RP-HPLC in bulk and pharmaceutical dosage form. Int J Res Pharm Sci. 2020;11(4):8047\u201353.","journal-title":"Int J Res Pharm Sci"},{"key":"1507_CR25","unstructured":"Wang W-G, Yun L-H, Wang R, Zhou X-Q. Simultaneous determination of metoprolol tartrate and felodipine in skin diffuse solution by HPLC. 2006;41:143\u20136."},{"issue":"6","key":"1507_CR26","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/molecules27061807","volume":"27","author":"F Hameedat","year":"2022","unstructured":"Hameedat F, Hawamdeh S, Alnabulsi S, Zayed A. High-performance liquid chromatography (HPLC) with fluorescence detection for quantification of steroids in clinical, pharmaceutical, and environmental samples: a review. Molecules. 2022;27(6):1807.","journal-title":"Molecules"},{"key":"1507_CR27","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2147\/DDDT.S318714","volume":"15","author":"AY Sayed","year":"2021","unstructured":"Sayed AY, Khalil NY, Almomen A, Alzoman NZ, Almehizia AA, Darwish IA. A highly sensitive nonextraction-assisted HPLC method with fluorescence detection for quantification of duvelisib in plasma samples and its application to pharmacokinetic study in rats. Drug Des Devel Ther. 2021;15:2667\u201377.","journal-title":"Drug Des Devel Ther"},{"key":"1507_CR28","unstructured":"US FDA. Guidance for industry: bioanalytical methods validation for human studies. Rockville, MD: Center for Drug Evaluation and Research, US Department of Health and Human Services; 2001."},{"key":"1507_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.chroma.2014.03.077","volume":"1353","author":"O Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez O, Blanco ME, Iriarte G, Bartolom\u00e9 L, Maguregui MI, Alonso RM. Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well-defined parameters limit of quantification, robustness, and matrix effect. J Chromatogr A. 2014;1353:10\u201327.","journal-title":"J Chromatogr A"},{"key":"1507_CR30","unstructured":"Latha P, Sailaja B. Bioanalytical method development and validation by HPLC: a review. 2021."},{"key":"1507_CR31","volume-title":"Introduction to modern liquid chromatography","author":"LR Snyder","year":"2010","unstructured":"Snyder LR, Kirkland JJ, Dolan JW. Introduction to modern liquid chromatography. 3rd ed. Hoboken: John Wiley & Sons; 2010.","edition":"3"},{"key":"1507_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-6395(05)80045-5","volume-title":"Handbook of pharmaceutical analysis by HPLC","author":"S Ahuja","year":"2005","unstructured":"Ahuja S, Dong MW. Handbook of pharmaceutical analysis by HPLC. Amsterdam: Elsevier; 2005."},{"key":"1507_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/9780470688427","volume-title":"Practical high-performance liquid chromatography","author":"VR Meyer","year":"2010","unstructured":"Meyer VR. Practical high-performance liquid chromatography. 5th ed. Chichester: Wiley; 2010.","edition":"5"},{"key":"1507_CR34","unstructured":"International Conference on Harmonization (ICH). Q2B: validation of analytical procedures: methodology. Federal Register. 1997;62."},{"key":"1507_CR35","unstructured":"ICH Expert Working Group. Validation of analytical procedures: methodology, ICH-Q2(R1). In: International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use. 2005."},{"issue":"Suppl 3","key":"1507_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2165\/00003495-198700343-00005","volume":"34","author":"B Edgar","year":"1987","unstructured":"Edgar B, Lundborg P, Reg\u00e5rdh CG. Clinical pharmacokinetics of felodipine. Drugs. 1987;34(Suppl 3):16\u201327.","journal-title":"Drugs"},{"issue":"4","key":"1507_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/cpt1975174400","volume":"17","author":"C Bengtsson","year":"1975","unstructured":"Bengtsson C, Johnsson G, Reg\u00e5rdh CG. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment. Clin Pharmacol Ther. 1975;17(4):400\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"1507_CR38","unstructured":"United States Pharmacopeia and National Formulary. USP43\u2013NF38. Rockville, MD: US Pharmacopeial Convention; 2020."},{"key":"1507_CR39","unstructured":"FDA Guidance for Industry. Bioanalytical Methods Validation for Human Studies. Center for Drug Evaluation and Research, US Department of Health and Human Services, Rockville, MD, USA; 2001."},{"issue":"3","key":"1507_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/10408349891199356","volume":"29","author":"PT Anastas","year":"1999","unstructured":"Anastas PT. Green chemistry and the role of analytical methodology development. Crit Rev Anal Chem. 1999;29(3):167\u201375.","journal-title":"Crit Rev Anal Chem"},{"issue":"3","key":"1507_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/analytica5030030","volume":"5","author":"FR Mansour","year":"2024","unstructured":"Mansour FR, P\u0142otka-Wasylka J, Locatelli M. Modified GAPI (MoGAPI) tool and software for the assessment of method greenness: case studies and applications. Analytica. 2024;5(3):451\u20137.","journal-title":"Analytica"},{"key":"1507_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2024.100120","volume":"10","author":"PM Nowak","year":"2024","unstructured":"Nowak PM, Arduini F. RGBfast\u2014a user-friendly version of the red-green-blue model for assessing greenness and whiteness of analytical methods. Green Anal Chem. 2024;10: 100120.","journal-title":"Green Anal Chem"},{"key":"1507_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.sampre.2025.100164","volume":"14","author":"FR Mansour","year":"2025","unstructured":"Mansour FR, Bedair A, Locatelli M. Click analytical chemistry index as a novel concept and framework, supported with open source software to assess analytical methods. Advances in Sample Preparation. 2025;14: 100164.","journal-title":"Advances in Sample Preparation"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01507-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T19:15:42Z","timestamp":1748027742000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01507-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1507"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01507-0","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Misr International University Institution Review Board (MIU IRB) affiliated with Misr International University, Cairo, Egypt and was conducted in compliance with applicable ethical guidelines and regulations. Approval was granted under IRB number MIU-IRB-2223-190.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests. The research was conducted independently without a relationship with a person or organization that could influence the collection, analysis, interpretation of data, manuscript writing and, in the decision, submitting the paper for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"141"}}